Stocks-6185.HK-CanSino Biologics Inc

6185.HK CanSino Biologics Inc

47.13 -0.70 (-1.46%)
Prices By Xignite, in HKD Market Closed
Invest
Stocks-6185.HK-CanSino Biologics Inc
6185.HK CanSino Biologics Inc
Invest

FINANCIAL SUMMARY

For the quarter ended 30/9/2022, CanSino Biologics Inc's revenues decreased by 43.47% and amounted to 86.56M. Net income decreased by 395.80% to -578.00M. Net assets decreased by 13.35% to 8.58B and EPS decreased from -0.52 to -2.26.
6185.HK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
78.03%
Net Profit Margin
-3,577.50%
Operating Margin
-16.15%
Return On Investment
-3.79%